Ausgabe 5/2013
Inhalt (11 Artikel)
Current Opinion
Genome-Based Bacterial Vaccines: Current State and Future Outlook
Alexandra Schubert-Unkmeir, Myron Christodoulides
Current Opinion
The Arrival of JAK Inhibitors: Advancing the Treatment of Immune and Hematologic Disorders
Yasuko Furumoto, Massimo Gadina
Leading Article
The Th17 Pathway as a Therapeutic Target in Rheumatoid Arthritis and Other Autoimmune and Inflammatory Disorders
Debbie M. Roeleveld, Annemarie E. M. van Nieuwenhuijze, Wim B. van den Berg, Marije I. Koenders
Review Article
A Review of Dendritic Cell Therapy for Cancer: Progress and Challenges
Gina M. Mantia-Smaldone, Christina S. Chu
Open Access
Review Article
Evolving Approaches to Metastatic Breast Cancer Patients Pre-treated with Anthracycline and Taxane
Shigehira Saji
Open Access
Review Article
Cationic Host Defence Peptides: Potential as Antiviral Therapeutics
Emily Gwyer Findlay, Silke M. Currie, Donald J. Davidson
Open Access
Original Research Article
Physicochemical and Functional Comparability Between the Proposed Biosimilar Rituximab GP2013 and Originator Rituximab
Jan Visser, Isabel Feuerstein, Thomas Stangler, Timo Schmiederer, Cornelius Fritsch, Martin Schiestl
Adis Drug Evaluation
Lixisenatide: A Review of Its Use in Patients with Type 2 Diabetes Mellitus
Lesley J. Scott
Adis Drug Clinical Q&A
Regorafenib: A Guide to Its Use in Advanced Gastrointestinal Stromal Tumor (GIST) After Failure of Imatinib and Sunitinib
Katherine A. Lyseng-Williamson
Adis Drug Clinical Q&A
Pegylated Liposomal Doxorubicin: A Guide to Its Use in Various Malignancies
Katherine A. Lyseng-Williamson, Sean T. Duggan, Gillian M. Keating